News

September 10, 2020

Ligand Expands OmniAb® Antibody Discovery Platform Through The Acquisitions of xCella Biosciences and Taurus Biosciences

April 9, 2019

xCella Announces New Antibody Development Program with Teva

April 8, 2019

xCella Biosciences presents talk and poster at PEGS Boston 2019

April 8, 2019

xCella Biosciences presents poster at Keystone Conference Antibodies as Drugs

March 20, 2017

xCella Licenses OmniAb Transgenic Platform for Antibody Discovery